This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evans, M. E.
Right arrow Articles by Titlow, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, M. E.
Right arrow Articles by Titlow, W. B.

 Previous Article

Antimicrobial Agents and Chemotherapy, March 1998, p. 727-727, Vol. 42, No. 3
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

LETTERS TO THE EDITOR

Selection of Fluoroquinolone-Resistant Methicillin-Resistant Staphylococcus aureus with Ciprofloxacin and Trovafloxacin

    LETTER
Top
Letter
References

Resistance to ciprofloxacin in methicillin-resistant Staphylococcus aureus emerges more rapidly than to ofloxacin, levofloxacin, or sparfloxacin (1, 2). We compared emergence of resistance to trovafloxacin with that to ciprofloxacin.

We examined 13 methicillin-resistant S. aureus isolates for which the ciprofloxacin and trovafloxacin MICs were <= 1 and <= 2 µg/ml, respectively, and for which unique genotypes were found by pulsed-field gel electrophoresis.

Spontaneous single-step mutation rates were determined by growing bacteria in antibiotic-free broth and plating 0.1-ml aliquots on Mueller-Hinton agar containing four or eight times the MIC of ciprofloxacin or trovafloxacin. The resistance frequency was calculated by dividing the number of colonies at 48 h by the inoculum. The emergence of resistance during serial transfer was studied by growing bacteria in antibiotic-free medium, adjusting the cultures to 108 CFU/ml, and spreading 0.2-ml aliquots onto Mueller-Hinton agar containing twofold dilutions (0.0625 to 32 µg/ml) of antibiotic. All colonies appearing at 48 h at the highest antibiotic concentration were collected by swab, regrown in antibiotic-free medium, and reinoculated onto another set of antibiotic-containing plates. All experiments were performed in duplicate. Single-step resistance rates and changes in the MIC with serial transfer were compared by the Wilcoxon signed rank test after log transformation of the data. The number of strains developing single-step resistance was compared by using Fisher's exact test.

Single-step resistance occurred in all strains exposed to 4× the MIC of ciprofloxacin but in only 4 (31%) strains exposed to trovafloxacin (P < 0.05). There was no difference in resistance rates at 8× the MIC of the antibiotics. The mean resistance rates at 4× the MIC of ciprofloxacin and trovafloxacin were 6.8 × 10-7 (range, <2.1 × 10-8 to 3.1 × 10-6) and 8.5 × 10-9 (range, <3.3 × 10-10 to 1.1 × 10-7), respectively (P < 0.05) (Table 1).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Single-step resistance rates in 13 methicillin-resistant S. aureus strains exposed to ciprofloxacin (cipro) or trovafloxacin (trova)

In serial transfer experiments, for all strains the mean MIC of ciprofloxacin increased 6.7 ± 0.9-fold, and the MIC of trovafloxacin increased 3.3 ± 0.9-fold (P < 0.05). The MICs for all strains exposed to ciprofloxacin increased by >= fourfold after a single transfer; the strains became resistant (MIC, >= 4 µg/ml) (3) within 4 transfers, and the MIC was >= 32 µg/ml after 10 transfers. In contrast, the MIC was 4 µg/ml for only one strain exposed to trovafloxacin. The mean MIC for the remaining strains was 2 µg/ml after 10 transfers.

Single-step resistance and the emergence of resistance with serial transfer appear to be more common with ciprofloxacin than with trovafloxacin.

    ACKNOWLEDGMENTS

This work was supported by Pfizer, Inc., New York.

    REFERENCES
Top
Letter
References

1. Kang, S. L., M. J. Rybak, B. J. McGrath, G. W. Kaatz, and S. M. Seo. 1994. Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model. Antimicrob. Agents Chemother. 38:2702-2709[Abstract/Free Full Text].
2. Kojima, T., M. Inoue, and M. Susumu. 1990. In vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 34:1123-1127[Abstract/Free Full Text].
3. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa.
Martin E. Evans
William B. Titlow
Division of Infectious Diseases
Department of Internal Medicine
University of Kentucky School of Medicine
800 Rose Street
Lexington, KY 40536


Antimicrobial Agents and Chemotherapy, March 1998, p. 727-727, Vol. 42, No. 3
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Butler, M. M., LaMarr, W. A., Foster, K. A., Barnes, M. H., Skow, D. J., Lyden, P. T., Kustigian, L. M., Zhi, C., Brown, N. C., Wright, G. E., Bowlin, T. L. (2007). Antibacterial Activity and Mechanism of Action of a Novel Anilinouracil-Fluoroquinolone Hybrid Compound. Antimicrob. Agents Chemother. 51: 119-127 [Abstract] [Full Text]  
  • Martin, C., Ofotokun, I., Rapp, R., Empey, K., Armitstead, J., Pomeroy, C., Hoven, A., Evans, M. (2005). Results of an antimicrobial control program at a university hospital. Am J Health Syst Pharm 62: 732-738 [Abstract] [Full Text]  
  • Campion, J. J., McNamara, P. J., Evans, M. E. (2004). Evolution of Ciprofloxacin-Resistant Staphylococcus aureus in In Vitro Pharmacokinetic Environments. Antimicrob. Agents Chemother. 48: 4733-4744 [Abstract] [Full Text]  
  • Butler, M. M., Skow, D. J., Stephenson, R. O., Lyden, P. T., LaMarr, W. A., Foster, K. A. (2002). Low Frequencies of Resistance among Staphylococcus and Enterococcus Species to the Bactericidal DNA Polymerase Inhibitor N3-Hydroxybutyl 6-(3'-Ethyl-4'-Methylanilino) Uracil. Antimicrob. Agents Chemother. 46: 3770-3775 [Abstract] [Full Text]  
  • Vaudaux, P., Francois, P., Bisognano, C., Schrenzel, J., Lew, D. P. (2002). Comparison of Levofloxacin, Alatrofloxacin, and Vancomycin for Prophylaxis and Treatment of Experimental Foreign-Body-Associated Infection by Methicillin-Resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 46: 1503-1509 [Abstract] [Full Text]  
  • Gootz, T. D., Zaniewski, R. P., Haskell, S. L., Kaczmarek, F. S., Maurice, A. E. (1999). Activities of Trovafloxacin Compared with Those of Other Fluoroquinolones against Purified Topoisomerases and gyrA and grlA Mutants of Staphylococcus aureus. Antimicrob. Agents Chemother. 43: 1845-1855 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evans, M. E.
Right arrow Articles by Titlow, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, M. E.
Right arrow Articles by Titlow, W. B.